Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss how platforms are being adapted for use in later stages of drug development as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.

[EPISODE 25] Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
On this episode of Molecular Moments, Jim McNally, Ph.D., speaks with Adam Stasio, president of SciMed, whose mission is to